ID   PXDN1_CAEEL             Reviewed;        1285 AA.
AC   Q1ENI8;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2006, sequence version 1.
DT   07-APR-2021, entry version 116.
DE   RecName: Full=Peroxidasin homolog pxn-1;
DE            EC=1.11.1.7 {ECO:0000250|UniProtKB:Q92626};
DE   Flags: Precursor;
GN   Name=pxn-1 {ECO:0000312|WormBase:ZK994.3};
GN   ORFNames=ZK994.3 {ECO:0000312|WormBase:ZK994.3};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-741 AND ASN-858, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.m600392-mcp200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
RN   [3]
RP   FUNCTION.
RX   PubMed=20876652; DOI=10.1242/dev.049189;
RA   Gotenstein J.R., Swale R.E., Fukuda T., Wu Z., Giurumescu C.A.,
RA   Goncharov A., Jin Y., Chisholm A.D.;
RT   "The C. elegans peroxidasin PXN-2 is essential for embryonic morphogenesis
RT   and inhibits adult axon regeneration.";
RL   Development 137:3603-3613(2010).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=25475546; DOI=10.14348/molcells.2015.2202;
RA   Lee J., Bandyopadhyay J., Lee J.I., Cho I., Park D., Cho J.H.;
RT   "A role for peroxidasin PXN-1 in aspects of C. elegans development.";
RL   Mol. Cells 38:51-57(2015).
RN   [5]
RP   FUNCTION.
RX   PubMed=26194821; DOI=10.14348/molcells.2015.0124;
RA   Cho I., Hwang G.J., Cho J.H.;
RT   "pxn-1 and pxn-2 May Interact Negatively during Neuronal Development and
RT   Aging in C. elegans.";
RL   Mol. Cells 38:729-733(2015).
CC   -!- FUNCTION: Plays a role in the attachment of tissues and in axonal
CC       guidance during early developmental stages (PubMed:25475546). May
CC       functionally antagonize the peroxidasin pxn-2 to maintain neuronal
CC       development (PubMed:20876652, PubMed:26194821).
CC       {ECO:0000269|PubMed:20876652, ECO:0000269|PubMed:25475546,
CC       ECO:0000269|PubMed:26194821}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 a phenolic donor + H2O2 = 2 a phenolic radical donor + 2
CC         H2O; Xref=Rhea:RHEA:56136, ChEBI:CHEBI:15377, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:139520, ChEBI:CHEBI:139521; EC=1.11.1.7;
CC         Evidence={ECO:0000250|UniProtKB:Q92626};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344; Evidence={ECO:0000250};
CC       Note=Binds 1 heme b (iron(II)-protoporphyrin IX) group covalently per
CC       subunit. {ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000269|PubMed:25475546}. Note=Localizes to the
CC       extracellular space in between body wall muscle cells.
CC       {ECO:0000269|PubMed:25475546}.
CC   -!- TISSUE SPECIFICITY: Expressed in the ventral nerve cord, the dorsal
CC       nerve cord, head neurons, GABAergic and cholinergic neurons, body wall
CC       muscles, vulval muscles, uterine muscles, intestine, the hypodermis and
CC       in coelomocytes. {ECO:0000269|PubMed:20876652,
CC       ECO:0000269|PubMed:25475546}.
CC   -!- DEVELOPMENTAL STAGE: Expressed from embryogenesis to adulthood.
CC       {ECO:0000269|PubMed:25475546}.
CC   -!- SIMILARITY: Belongs to the peroxidase family. XPO subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00298}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX284605; CCD71290.1; -; Genomic_DNA.
DR   RefSeq; NP_505188.3; NM_072787.3.
DR   SMR; Q1ENI8; -.
DR   BioGRID; 56017; 3.
DR   STRING; 6239.ZK994.3; -.
DR   PeroxiBase; 3359; CelPxd01.
DR   iPTMnet; Q1ENI8; -.
DR   EPD; Q1ENI8; -.
DR   PaxDb; Q1ENI8; -.
DR   PeptideAtlas; Q1ENI8; -.
DR   EnsemblMetazoa; ZK994.3.1; ZK994.3.1; WBGene00004256.
DR   GeneID; 191484; -.
DR   KEGG; cel:CELE_ZK994.3; -.
DR   UCSC; ZK994.3; c. elegans.
DR   CTD; 191484; -.
DR   WormBase; ZK994.3; CE40298; WBGene00004256; pxn-1.
DR   eggNOG; KOG0619; Eukaryota.
DR   eggNOG; KOG2408; Eukaryota.
DR   GeneTree; ENSGT00940000168557; -.
DR   HOGENOM; CLU_006087_0_0_1; -.
DR   InParanoid; Q1ENI8; -.
DR   OMA; HYLNMIA; -.
DR   OrthoDB; 276568at2759; -.
DR   PhylomeDB; Q1ENI8; -.
DR   Reactome; R-CEL-209968; Thyroxine biosynthesis.
DR   Reactome; R-CEL-6798695; Neutrophil degranulation.
DR   Reactome; R-CEL-8941413; Events associated with phagocytolytic activity of PMN cells.
DR   PRO; PR:Q1ENI8; -.
DR   Proteomes; UP000001940; Chromosome V.
DR   Bgee; WBGene00004256; Expressed in material anatomical entity and 4 other tissues.
DR   GO; GO:0005604; C:basement membrane; IDA:WormBase.
DR   GO; GO:0031012; C:extracellular matrix; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004601; F:peroxidase activity; IBA:GO_Central.
DR   GO; GO:0010172; P:embryonic body morphogenesis; IEA:InterPro.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0016203; P:muscle attachment; IMP:UniProtKB.
DR   GO; GO:1902669; P:positive regulation of axon guidance; IMP:UniProtKB.
DR   GO; GO:0048679; P:regulation of axon regeneration; IEA:InterPro.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:InterPro.
DR   CDD; cd09826; peroxidasin_like; 1.
DR   Gene3D; 1.10.640.10; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR019791; Haem_peroxidase_animal.
DR   InterPro; IPR010255; Haem_peroxidase_sf.
DR   InterPro; IPR037120; Haem_peroxidase_sf_animal.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR000372; LRRNT.
DR   InterPro; IPR034824; Peroxidasin_peroxidase.
DR   InterPro; IPR034826; Peroxidasin_PXN-1_nema.
DR   PANTHER; PTHR11475:SF74; PTHR11475:SF74; 1.
DR   Pfam; PF03098; An_peroxidase; 1.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF13855; LRR_8; 2.
DR   Pfam; PF01462; LRRNT; 1.
DR   PRINTS; PR00457; ANPEROXIDASE.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00408; IGc2; 2.
DR   SMART; SM00369; LRR_TYP; 3.
DR   SMART; SM00082; LRRCT; 1.
DR   SMART; SM00013; LRRNT; 1.
DR   SUPFAM; SSF48113; SSF48113; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   PROSITE; PS50835; IG_LIKE; 2.
DR   PROSITE; PS50292; PEROXIDASE_3; 1.
PE   1: Evidence at protein level;
KW   Calcium; Coiled coil; Disulfide bond; Extracellular matrix; Glycoprotein;
KW   Heme; Hydrogen peroxide; Immunoglobulin domain; Iron; Leucine-rich repeat;
KW   Metal-binding; Oxidoreductase; Peroxidase; Reference proteome; Repeat;
KW   Secreted; Signal.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..1285
FT                   /note="Peroxidasin homolog pxn-1"
FT                   /id="PRO_0000319623"
FT   DOMAIN          21..52
FT                   /note="LRRNT"
FT   REPEAT          53..74
FT                   /note="LRR 1"
FT   REPEAT          77..100
FT                   /note="LRR 2"
FT   REPEAT          101..122
FT                   /note="LRR 3"
FT   REPEAT          124..145
FT                   /note="LRR 4"
FT   REPEAT          148..169
FT                   /note="LRR 5"
FT   DOMAIN          181..230
FT                   /note="LRRCT"
FT   DOMAIN          315..401
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          408..495
FT                   /note="Ig-like C2-type 2"
FT   COILED          508..550
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        720
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   METAL           721
FT                   /note="Calcium"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   METAL           803
FT                   /note="Calcium"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   METAL           805
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   METAL           807
FT                   /note="Calcium"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   METAL           809
FT                   /note="Calcium"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   METAL           973
FT                   /note="Iron (heme axial ligand)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   BINDING         719
FT                   /note="Heme; covalent, via 2 links"
FT                   /evidence="ECO:0000250"
FT   BINDING         877
FT                   /note="Heme; covalent, via 2 links"
FT                   /evidence="ECO:0000250"
FT   SITE            874
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   CARBOHYD        49
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        248
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        595
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        741
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:17761667"
FT   CARBOHYD        858
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:17761667"
FT   DISULFID        336..385
FT                   /evidence="ECO:0000250"
FT   DISULFID        429..479
FT                   /evidence="ECO:0000250"
FT   DISULFID        625..641
FT                   /evidence="ECO:0000250"
FT   DISULFID        740..750
FT                   /evidence="ECO:0000250"
FT   DISULFID        744..771
FT                   /evidence="ECO:0000250"
FT   DISULFID        1076..1133
FT                   /evidence="ECO:0000250"
FT   DISULFID        1174..1201
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   1285 AA;  146337 MW;  B7110A400C54655D CRC64;
     MNLYLLLLVI ATSSWQFVAG LECPVECTCD KKGLVVDCSS SGLTRIPKNI SRNVRSLVIR
     NNRIHKLKRS DLEGFNQLET LVLTHNKIKI IEENVLDHLP ELKRLSLAHN ELVYIPPLCS
     DSRPLASLNL KRNHIQFIDE QVLRYFPDLT QLDFSHNRIQ SLRTKLFDNL PALSHAHLHS
     NPWHCDCRAS KVKALLQKVK WEKKVYCTNP VELRHQALDE VDDSALTCAR PAEESWTGEE
     IKLTCAKNSS SKLVVWMYEN VEVDSSSLDG YEIHDTVITV PRKTNVNFMT CTYDFDHIPH
     HRRLRQSQHQ GNGSPQFTYK PRDNSFREGS EVKVNCEVMG NPKPTINWYH NGKRFISSRK
     RQLGLSNNVL RIYPFLEEDS GRYTCEAVNS VGKVRHAFSL DLISSVPPNI YEGPQSVSQN
     LGGSVVFVCK ANGNPVPDYT WSFDGSTIGH IKGRFMVSDD GTELRISNIE KKDEGYYSCM
     AGNPVGAMSA DAKLTVIGGE TRKAAAPQID EELLRAIAQK ARQNVENAVE KTRKQLTQDK
     VTNTNDLKRL FRFSTPKQAV ELSKAREIYE ESVRLVREHV EKGLILNVDE LHPKNVSYES
     VLHVTHVQAL MGLSGCHTGQ YKNPCTDTCF HHRYRSFDGQ CNNKNKPMTG VSLMPLRRLL
     KPVYENGFNT PVGWEKGRLY NGYPLPNVRE VSRQLVATEN ITPHSKLSSM VMQWGQFVDH
     DLTHTVTALS RHSYATGAFC NRTCENLDPC FNIPLSPNDP RVKSGSAKYP CIEFERSAAV
     CGSGETSLVF NRVTYREQMN ALTSFLDASN VYGSNEVQAQ ELRDTYNNNG MLRFDITSEA
     GKEYLPFEKD SNMDCRRNFS EENPIRCFLA GDLRANEQLA LAATHTIFIR EHNRIAKKLK
     SMNGNWDGEI IYHETRKIVG AMMQHITYKH WMPIIFGGQA QMNKFVGTYQ GYDPDVDASV
     TNAFATAAFR FGHTIINPSL FRLGNDFMPI KEGHIALHKA FFTPELVLTQ GGVDPLLRGL
     FASPLKHPMP TQLLNMELIE KLFMKGHEVS LDLAVMNIQR SRDHGLPSYT EYRKFCNLPV
     PVQWEDMKGY IKDDMIIQKL RGLYGVPQNI DLWVGGIVEE KLENGLFGPT FACIIGEQFR
     KIRDGDRFWY EKDGVFTPEQ LREIKKITLA RLFCDNGDNI DRIQKDVFMY PGMDKENYGT
     CQETEMMNLR AWSKCCDNVC PTMLDRILRS RHRGSRLHGC NQNGIWRPEG AKWIPQNEIC
     TECVCQGSRV WCSTKEDCSD NRSPF
//
